Nexalin Technology (NXL) Asset Utilization Ratio (2022 - 2026)
Nexalin Technology's (NXL) quarterly Asset Utilization Ratio came in at 0.07 in Q1 2026, up 79.79% year-on-year from 0.04 in Q1 2025, and up 7.06% quarter-over-quarter from 0.06 in Q4 2025.
Nexalin Technology (NXL) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Nexalin Technology's Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.07 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 79.79% year-over-year to 0.07 in Q1 2026; TTM through Mar 2026 was 0.07, a 79.79% increase from a year earlier, with the FY2025 full-year figure at 0.07, up 58.53% from the prior year.
- Asset Utilization Ratio grew to 0.07 in Q1 2026 per NXL's latest filing, from 0.06 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.17 in Q4 2022 and bottomed at 0.03 in Q3 2023.
- The 5-year median for Asset Utilization Ratio is 0.05 (2024), against an average of 0.07.
- Across the five-year window, Asset Utilization Ratio plunged 83.6% in 2023 and jumped 79.79% in 2026, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.17 in 2022, then plunged by 83.6% to 0.03 in 2023, then rose by 29.62% to 0.04 in 2024, then jumped by 73.63% to 0.06 in 2025, then climbed by 7.06% to 0.07 in 2026.
- Per Business Quant, the three latest NXL Asset Utilization Ratio figures stand at 0.07 (Q1 2026), 0.06 (Q4 2025), and 0.03 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.12 |
| Mar 31, 2023 | 0.15 |
| Dec 31, 2022 | 0.17 |